Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-16 05:34 | 2025-12-11 | ROIV | Roivant Sciences Ltd. | Ramaswamy Vivek | 10% owner | Pharmaceutical Preparations | OPT+S | $21.89 | 3,103,745 | $67,942,220 | 34,132,463 | -8.3% |
| 2025-11-18 01:52 | 2025-11-13 | ROIV | Roivant Sciences Ltd. | Ramaswamy Vivek | 10% owner | Pharmaceutical Preparations | SALE | $20.46 | 1,854,603 | $37,939,057 | 33,653,756 | -5.2% |
| 2025-11-08 02:50 | 2025-11-05 | ASST | Strive, Inc. | Ramaswamy Vivek | 10% owner | Finance Services | BUY | $80.00 | 15,625 | $1,250,000 | 15,625 | +100.0% |
| 2025-09-06 00:01 | 2025-09-03 | ROIV | Roivant Sciences Ltd. | Ramaswamy Vivek | 10% owner | Pharmaceutical Preparations | SALE | $12.65 | 1,775,749 | $22,456,122 | 35,508,359 | -4.8% |
| 2025-06-23 18:35 | 2025-06-18 | ROIV | Roivant Sciences Ltd. | Ramaswamy Vivek | 10% owner | Pharmaceutical Preparations | SALE | $11.46 | 1,142,273 | $13,084,851 | 37,284,108 | -3.0% |
| 2025-06-07 00:49 | 2025-06-04 | ROIV | Roivant Sciences Ltd. | Ramaswamy Vivek | 10% owner | Pharmaceutical Preparations | SALE | $11.30 | 748,230 | $8,454,775 | 38,426,381 | -1.9% |
| 2025-05-09 03:51 | 2025-05-06 | ROIV | Roivant Sciences Ltd. | Ramaswamy Vivek | 10% owner | Pharmaceutical Preparations | SALE | $11.27 | 898,959 | $10,129,830 | 39,174,611 | -2.2% |
| 2024-01-04 00:56 | 2024-01-02 | ROIV | Roivant Sciences Ltd. | Ramaswamy Vivek | 10% owner | Pharmaceutical Preparations | SALE | $11.05 | 3,000,000 | $33,150,000 | 51,929,426 | -5.5% |
| 2023-02-23 01:04 | 2023-02-22 | ROIV | Roivant Sciences Ltd. | Ramaswamy Vivek | Director | Pharmaceutical Preparations | SALE | $7.95 | 4,000,000 | $31,800,000 | 54,409,211 | -6.8% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.